We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

125 hedge funds and large institutions have $260M invested in Rigel Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 36 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

48,650% more call options, than puts

Call options by funds: $975K | Put options by funds: $2K

22% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 36

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

2% more funds holding

Funds holding: 123 → 125 (+2)

4% more capital invested

Capital invested by funds: $250M → $260M (+$9.94M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.16% less ownership

Funds ownership: 77.88% → 77.72% (-0.16%)

Holders
125
Holders Change
+2
Holders Change %
+1.63%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
20
Increased
44
Reduced
36
Closed
18
Calls
$975K
Puts
$2K
Net Calls
+$973K
Net Calls Change
+$678K

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$2.98M
2
Goldman Sachs
Goldman Sachs
New York
+$2.33M
3
GC
Globeflex Capital
California
+$2.18M
4
LSV Asset Management
LSV Asset Management
Illinois
+$1.81M
5
Wells Fargo
Wells Fargo
California
+$1.71M

Top Sellers

Rank Fund Capital Flow
1
SCM
Soleus Capital Management
Connecticut
-$8.96M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$5.36M
3
Invesco
Invesco
Georgia
-$2.16M
4
Pacer Advisors
Pacer Advisors
Pennsylvania
-$2.03M
5
BlackRock
BlackRock
New York
-$2.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$1.93M -$227K -11,951 -10%
Wells Fargo
27
Wells Fargo
California
$1.85M +$1.71M +90,046 +1,023%
LSV Asset Management
28
LSV Asset Management
Illinois
$1.79M +$1.81M +95,700 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.74M +$824K +43,463 +88%
VOYA Investment Management
30
VOYA Investment Management
Georgia
$1.74M +$123K +6,501 +8%
Los Angeles Capital Management
31
Los Angeles Capital Management
California
$1.54M -$419K -22,107 -21%
Charles Schwab
32
Charles Schwab
California
$1.45M +$211K +11,154 +17%
BGIM
33
Brandywine Global Investment Management
Pennsylvania
$1.44M +$1.46M +76,870 New
UBS Group
34
UBS Group
Switzerland
$1.27M +$405K +21,341 +46%
Wellington Management Group
35
Wellington Management Group
Massachusetts
$1.2M +$45.9K +2,422 +4%
State of Wisconsin Investment Board
36
State of Wisconsin Investment Board
Wisconsin
$1.19M -$268K -14,112 -18%
Prudential Financial
37
Prudential Financial
New Jersey
$1.12M +$208K +10,953 +22%
Barclays
38
Barclays
United Kingdom
$1.12M +$580K +30,595 +105%
Massachusetts Financial Services
39
Massachusetts Financial Services
Massachusetts
$958K +$337K +17,764 +53%
CCA
40
Carrera Capital Advisors
Michigan
$942K +$954K +50,299 New
GCP
41
GSA Capital Partners
United Kingdom
$766K -$71.4K -3,765 -8%
Two Sigma Investments
42
Two Sigma Investments
New York
$718K +$487K +25,664 +202%
Mackenzie Financial
43
Mackenzie Financial
Ontario, Canada
$709K +$717K +37,827 New
SSA
44
Sierra Summit Advisors
Nevada
$698K +$707K +37,269 New
Squarepoint
45
Squarepoint
New York
$678K +$268K +14,135 +64%
SBH
46
Segall Bryant & Hamill
Illinois
$674K – – –
BCM
47
Bridgeway Capital Management
Texas
$655K -$237K -12,500 -26%
AllianceBernstein
48
AllianceBernstein
Tennessee
$589K – – –
Millennium Management
49
Millennium Management
New York
$585K +$593K +31,259 New
Two Sigma Advisers
50
Two Sigma Advisers
New York
$583K -$205K -10,811 -26%
1
2
3 4 5

RIGL Hedge Fund Activity: Q2 2025 in Review

125 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q2 2025, worth a combined $260M — up 4% from $250M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new RIGL positions and 18 closed out — a net gain of 2 holders — while 44 added to existing stakes and 36 trimmed.

The largest buyer was Marshall Wace, adding an estimated $2.98M. The largest seller was Soleus Capital Management, cutting an estimated $8.96M.

  • 125 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q2 2025, up from 123 in Q1 2025.
  • Funds reported $260M of Rigel Pharmaceuticals stock for Q2 2025, up 4% quarter-over-quarter.
  • 20 funds opened new Rigel Pharmaceuticals positions in Q2 2025 and 18 closed out, a net change of +2 holders.
  • The largest Rigel Pharmaceuticals buyer in Q2 2025 was Marshall Wace, an estimated $2.98M added.
  • The largest Rigel Pharmaceuticals seller in Q2 2025 was Soleus Capital Management, an estimated $8.96M sold.

Based on aggregated 13F filings for Q2 2025.